Loss of Caspase-9 Provides Genetic Evidence for the Type I/II Concept of CD95-mediated Apoptosis
Open Access
- 1 October 2006
- journal article
- research article
- Published by Elsevier
- Vol. 281 (40) , 29652-29659
- https://doi.org/10.1074/jbc.m603487200
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Caspase-8 Can Be Activated by Interchain Proteolysis without Receptor-triggered Dimerization during Drug-induced ApoptosisJournal of Biological Chemistry, 2005
- Type I and type II reactions in TRAIL-induced apoptosis – results from dose–response studiesOncogene, 2004
- A new quantitative assay for cytochrome c release in apoptotic cellsCell Death & Differentiation, 2003
- The CD95(APO-1/Fas) DISC and beyondCell Death & Differentiation, 2003
- Proapoptotic BAX and BAK: A Requisite Gateway to Mitochondrial Dysfunction and DeathScience, 2001
- Fas triggers an alternative, caspase-8–independent cell death pathway using the kinase RIP as effector moleculeNature Immunology, 2000
- Bcl-2 does not inhibit cell death induced by the physiological Fas ligand: implications for the existence of type I and type II cellsCell Death & Differentiation, 2000
- Letter to the EditorCell Death & Differentiation, 1999
- Bid-deficient mice are resistant to Fas-induced hepatocellular apoptosisNature, 1999
- Two CD95 (APO-1/Fas) signaling pathwaysThe EMBO Journal, 1998